Tag: Digital therapeutics
Akili, Inc. Announces Major Workforce Reduction Amid Strategic Shifts in Digital Therapeutics
Prescription digital therapeutics company Akili, Inc. (Nasdaq: AKLI) recently announced a significant Akili workforce reduction digital therapeutics event, terminating nearly half of its remaining...
Akili Inc. Shifts Strategy to Non-Prescription Digital Therapeutics Amid Workforce Reductions
Akili Inc., a Boston-based leader in digital therapeutics, is undergoing a major transformation. The company announced that it will lay off 40% of its...
Digital Therapeutics Reimbursement: New Clarity for Behavioral Health
After years of uncertainty around digital therapeutics reimbursement, the industry is finally beginning to gain clarity. Digital therapeutics (DTx) are evidence-based treatments delivered through...
Akili Interactive Goes Public via SPAC Merger, Signaling Growing Momentum for Digital Therapeutics
Akili Interactive (Nasdaq: AKLI), a trailblazer in the emerging field of prescription digital therapeutics and a leader in digital therapeutics for ADHD, officially entered...
Biden Administration Advances Digital Therapeutics Reimbursement to Expand Access to Substance Use Disorder Treatment
The Biden Administration is driving forward an innovative approach to tackling the nation’s substance use crisis by promoting new reimbursement strategies for digital therapeutics...